Lombard Odier Asset Management (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.07M	Sell	3,314 -569	-15%	-$387K	0.07%	223
2026 Q1	$3M	Buy	+3,883	New	+$2.97M	0.11%	167
2023 Q2	–	Sell	-1,630	Closed	-$1.34M	–	329
2023 Q1	$1.34M	Buy	1,630 +163	+11%	+$123K	0.12%	158
2022 Q4	$1.06M	Buy	1,467 +601	+69%	+$443K	0.08%	176
2022 Q3	$597K	Sell	866 -482	-36%	-$303K	0.05%	182
2022 Q2	$797K	Buy	+1,348	New	+$876K	0.07%	171
2022 Q1	–	Sell	-999	Closed	-$631K	–	346
2021 Q4	$631K	Buy	+999	New	+$614K	0.04%	208
2021 Q3	–	Sell	-1,161	Closed	-$648K	–	424
2021 Q2	$648K	Sell	1,161 -133	-10%	-$67.4K	0.03%	278
2021 Q1	$612K	Buy	+1,294	New	+$630K	0.04%	218
2020 Q4	–	Sell	-2,933	Closed	-$1.64M	–	309
2020 Q3	$1.64M	Buy	+2,933	New	+$1.78M	0.17%	91
2020 Q2	–	Sell	-2,625	Closed	-$1.28M	–	297
2020 Q1	$1.28M	Buy	+2,625	New	+$1.08M	0.17%	93
2019 Q3	–	Sell	-1,305	Closed	-$408K	–	380
2019 Q2	$408K	Hold	1,305	–	–	0.04%	253
2019 Q1	$536K	Buy	+1,305	New	+$537K	0.05%	233
2016 Q2	–	Sell	-393	Closed	-$142K	–	413
2016 Q1	$142K	Hold	393	–	–	0.02%	309
2015 Q4	$216K	Buy	+393	New	+$213K	0.03%	252
2015 Q3	–	Sell	-393	Closed	-$200K	–	381
2015 Q2	$200K	Sell	393 -216	-35%	-$105K	0.02%	416
2015 Q1	$276K	Buy	+609	New	+$258K	0.03%	335
2014 Q4	–	Sell	-52,917	Closed	-$19.1M	–	626
2014 Q3	$19.1M	Buy	52,917 +51,985	+5,578%	+$17.4M	0.49%	48
2014 Q2	$262K	Buy	+932	New	+$276K	0.03%	321

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s REGN Position: Q2 2026 in Review

Lombard Odier Asset Management (Switzerland) reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, selling an estimated $387K and leaving 3,314 shares worth $2.07M. The position accounts for 0.07% of the portfolio, ranked #223.

Lombard Odier Asset Management (Switzerland) first reported a position in REGN in Q2 2014 and has held it in 19 quarters since. The position peaked at $19.1M in Q3 2014. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Lombard Odier Asset Management (Switzerland) held 3,314 shares of Regeneron Pharmaceuticals worth $2.07M as of Q2 2026.
Lombard Odier Asset Management (Switzerland) sold 569 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $387K.
Regeneron Pharmaceuticals made up 0.07% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #223 holding.
Lombard Odier Asset Management (Switzerland) first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 19 quarters since.
Lombard Odier Asset Management (Switzerland)'s Regeneron Pharmaceuticals position peaked at $19.1M in Q3 2014.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.